Answers are grounded in this paper and cite their sources.
The study demonstrates improved antibacterial and antibiofilm activity of ciprofloxacin-loaded nanoparticles against resistant bacteria, suggesting a new treatment option.
Nanotechnology is becoming critical in the treatment of antibiotic-resistant bacteria infections. Ciprofloxacin was repurposed in this research by conjugation to sodium dodecyl sulfate (SDS)-capped silver nanoparticles (Cip-SDS-AgNPs) to promote antimicrobial activity. Nano-conjugates were chemically reduced with sodium borohydride (NaBH₄) and stabilized by SDS; reduction of Ag⁺ to elemental silver formed a deep yellow colloid, which changed to a deep orange after loading with ciprofloxacin, which demonstrated successful incorporation. The evaluation of antibacterial activity was conducted against Gram-negative (Pseudomonas aeruginosa, Escherichia coli) and Gram-positive (Staphylococcus aureus, Listeria monocytogenes) resistant bacteria. Among all the formulations, Cip-SDS-AgNPs demonstrated better inhibition zones (E. coli 28 mm; P. aeruginosa 25 mm; S. aureus 32 mm; L. monocytogenes 37 mm) than SDS-AgNPs, unmodified AgNPs and free ciprofloxacin. UV-visible spectroscopy, FTIR and SEM were used to confirm the morphology, surface characterization, and stability of nanoparticle formulations. Cip-SDS-AgNPs also displayed the highest anti-biofilm activity (tube assay and tissue-culture plate method) and a strong antioxidant potential in DPPH assay (85% scavenging at 100 ugmL⁻¹), compared to SDS-AgNPs, and bare AgNPs. P. aeruginosa was found to be the most susceptible via MIC and MBC determination (MIC 25 ugmL⁻¹; MBC 50 ugmL⁻¹), demonstrating the enhanced potency of Cip-SDS-AgNPs against prominent clinical bacterial strains. The formulation demonstrates the potential as a biocompatible, non-toxic carrier of effective drug delivery and increased antimicrobial efficacy. This study provides a new approach of repurposing ciprofloxacin by conjugation with nanoparticles, which offers a dual-action system with increased anti-bacterial and anti-biofilm performance against resistant strains.
No takes yet. Share an insight, caveat, or question.
Fareed et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: